Cart
sales@molnova.com
Rhamnocitrin
CAS No. 569-92-6
Rhamnocitrin( —— )
Catalog No. M24562 CAS No. 569-92-6
Rhamnocitrin can enhance the immune function, improve the formation of spleen cells of mice serum hemolysin of chicken red blood cell immune.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 240 | In Stock |
|
| 5MG | 155 | In Stock |
|
| 10MG | 264 | In Stock |
|
| 25MG | 449 | In Stock |
|
| 50MG | 631 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRhamnocitrin
-
NoteResearch use only, not for human use.
-
Brief DescriptionRhamnocitrin can enhance the immune function, improve the formation of spleen cells of mice serum hemolysin of chicken red blood cell immune.
-
DescriptionRhamnocitrin can enhance the immune function, improve the formation of spleen cells of mice serum hemolysin of chicken red blood cell immune.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number569-92-6
-
Formula Weight300.27
-
Molecular FormulaC16H12O6
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO=C1C(O)=C(C2=CC=C(O)C=C2)OC3=CC(OC)=CC(O)=C13
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Anticataract activity of rhamnocitrin isolated from Bauhinia variegata stem bark.Oriental Pharmacy and Experimental Medicine,2012,12(3):227 -32.
molnova catalog
related products
-
Barbadin
Barbadin is a novel and specific inhibitor of β-arrestin/β2-adaptin interaction with an IC50 value of 19.1 μM for β-arestin1 and 15.6 μM for β-arestin2.
-
Cerdulatinib hydroch...
Cerdulatinib (PRT-062070) is an oral active, multi-targeted tyrosine kinase inhibitor with IC50 of 12 nM/6 nM/8 nM/0.5 nM and 32 nM for JAK1/JAK2/JAK3/TYK2 and Syk, respectively.
-
VULM 1457
VULM 1457 is a potent ACAT inhibitor. VULM 1457 has remarkable hypolipidaemic activity and improves the overall myocardial ischaemia-reperfusion injury outcomes.
